PODD vs TERN · P/E 34, rev $2.07B vs $6.12B cap
Insulet Corporation (PODD) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PODD and TERN stock pages for the full models.
Not investment advice.